SpectraCure AB (SPEC) — Cash Flow-to-Debt Ratio
SpectraCure AB (SPEC) has a Cash Flow-to-Debt Ratio of -0.41x as of December 2025, meaning its operating cash flow of Skr-4.48 Million could theoretically repay 0% of its total liabilities (Skr10.92 Million) in one year. See SpectraCure AB free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
SpectraCure AB Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for SpectraCure AB across 12 annual periods. Also explore SpectraCure AB (SPEC) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for SpectraCure AB (2014–2025)
Year-by-year debt coverage analysis for SpectraCure AB. For market capitalisation and broader financial context, see market value of SpectraCure AB.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.20x | Skr-24.03 Million | Skr10.92 Million | ▼ -42.6% |
| 2024 | -1.54x | Skr-21.83 Million | Skr14.15 Million | ▼ -23.7% |
| 2023 | -1.25x | Skr-18.68 Million | Skr14.97 Million | ▲ +34.2% |
| 2022 | -1.89x | Skr-22.96 Million | Skr12.12 Million | ▼ -51.1% |
| 2021 | -1.25x | Skr-18.60 Million | Skr14.84 Million | ▼ -77.5% |
| 2020 | -0.71x | Skr-9.40 Million | Skr13.32 Million | ▲ +12.8% |
| 2019 | -0.81x | Skr-10.05 Million | Skr12.41 Million | ▲ +63.6% |
| 2018 | -2.23x | Skr-8.97 Million | Skr4.03 Million | ▼ -145.8% |
| 2017 | 4.86x | Skr6.33 Million | Skr1.30 Million | ▲ +265.2% |
| 2016 | -2.94x | Skr-19.60 Million | Skr6.66 Million | ▲ +68.6% |
| 2015 | -9.38x | Skr-9.71 Million | Skr1.04 Million | ▼ -13341.8% |
| 2014 | -0.07x | Skr-604.49K | Skr8.66 Million | — |